Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.

Thrombosis and inflammation are closely related. However, the response of the vein wall to venous thrombosis has been poorly documented. This study examines the hypothesis that venous thrombosis is associated with an inflammatory response in the vein wall. In a rat model of inferior vena caval thrombosis, vein wall was temporally examined for inflammation by assessment of histopathology, leukocyte morphometrics, and cytokine levels. Animals were killed 1 hour and 1, 3, and 6 days after thrombus induction. Our findings demonstrated an early (day 1) neutrophil infiltration into the vein wall followed by a later (days 3 and 6) monocyte/macrophage and lymphocyte response. Cytokines were elevated only under conditions of venous thrombosis. Levels of epithelial neutrophil activating protein-78 (ENA-78), tumor necrosis factor-alpha (TNF), interleukin-6, and JE/monocyte chemoattractant protein-1 (JE/MCP-1) increased over the 6-day period, while macrophage inflammatory protein-1 alpha (MIP-1 alpha) peaked at day 3 after thrombus induction. Additionally, rats were passively immunized with neutralizing antibodies to TNF, ENA-78, MIP-1 alpha, JE/MCP-1, intercellular adhesion molecule-1 (ICAM-1), and CD18 compared with control antibodies. The most effective antibody early after thrombus induction for attenuating vein wall neutrophil extravasation was anti-TNF (P < .01). The monocyte/macrophage extravasation was inhibited most by anti-ICAM-1 followed by anti-TNF (P < .01). These findings demonstrate that venous thrombosis is associated with significant vein wall inflammation that is partially inhibited by neutralizing antibodies to cytokines and adhesion molecules.

[1]  M. Miyasaka,et al.  Identification of monoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. , 1990, International immunology.

[2]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[3]  Michael Loran Dustin,et al.  The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. , 1987, Annual review of immunology.

[4]  A. Cerami,et al.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Esmon,et al.  Protein C and the Endothelium , 1988, Seminars in thrombosis and hemostasis.

[6]  J. Farber.  HuMig: a new human member of the chemokine family of cytokines. , 1993, Biochemical and biophysical research communications.

[7]  A. Arbor,et al.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. , 1994, Circulation research.

[8]  D. E. Strandness,et al.  Deep venous insufficiency: the relationship between lysis and subsequent reflux. , 1993, Journal of vascular surgery.

[9]  Michael Loran Dustin,et al.  Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells , 1988, The Journal of cell biology.

[10]  M. Monreal,et al.  Comparative study on the antithrombotic efficacy of four low-molecular-weight heparins in three different models of experimental venous thrombosis. , 1991, Haemostasis.

[11]  C. Smith,et al.  Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine. , 1992, Journal of immunology.

[12]  C. Wolf‐Peeters,et al.  Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. , 1993, Journal of immunology.

[13]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Smith,et al.  Role of β1 β2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes , 1993 .

[15]  M. Burdick,et al.  A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). , 1992, Immunological investigations.

[16]  James T. Elder,et al.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. , 1991, The American journal of pathology.

[17]  T. Standiford,et al.  Human neutrophils exhibit disparate chemotactic factor gene expression. , 1990, Biochemical and biophysical research communications.

[18]  C. Smith,et al.  Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. , 1992, Journal of immunology.

[19]  G. de Gaetano,et al.  Failure of aspirin at different doses to modify experimental thrombosis in rats. , 1980, Thrombosis research.

[20]  F. S. Becker,et al.  Cytokine-induced neutrophil-derived interleukin-8. , 1992, The American journal of pathology.

[21]  E. Butcher.  Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[22]  G. Stewart.  Neutrophils and deep venous thrombosis. , 1993, Haemostasis.

[23]  R. Strieter,et al.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. , 1989, The Journal of biological chemistry.

[24]  R. Strieter,et al.  Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 , 1991, The Journal of experimental medicine.

[25]  R. Strieter,et al.  Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor. , 1988, Biochemical and biophysical research communications.

[26]  M. Burdick,et al.  The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. , 1992, Immunological investigations.

[27]  R. Strieter,et al.  Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. , 1991, Kidney international.

[28]  R. Strieter,et al.  Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. , 1990, Journal of immunology.

[29]  K. Matsushima,et al.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. , 1989, Cytokine.

[30]  T. Standiford,et al.  Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. , 1991, American journal of respiratory cell and molecular biology.

[31]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[32]  R. Strieter,et al.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.

[33]  R. Strieter,et al.  The bimodal expression of tumor necrosis factor-alpha in association with rat lung reimplantation and allograft rejection. , 1993, Journal of immunology.

[34]  M. Baggiolini,et al.  Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases , 1990, The Journal of experimental medicine.

[35]  M. Cybulsky,et al.  Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. , 1991, Journal of immunology.

[36]  M. Burdick,et al.  Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. , 1993, Immunological investigations.

[37]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[38]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[39]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.

[40]  L. Greenfield,et al.  Inflammatory and Procoagulant Mediator Interactions in an Experimental Baboon Model of Venous Thrombosis , 1993, Thrombosis and Haemostasis.

[41]  J. Keller,et al.  Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.

[42]  W. Konigsberg,et al.  Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. , 1989, Thrombosis research.

[43]  M. Gimbrone,et al.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.

[44]  D. Stern,et al.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.

[45]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[46]  Michael Loran Dustin,et al.  Supergene families meet in the immune system. , 1988, Immunology today.

[47]  T. Standiford,et al.  Expression and regulation of macrophage inflammatory protein-1 alpha by murine alveolar and peritoneal macrophages. , 1994, American journal of respiratory cell and molecular biology.

[48]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[49]  S. Benatar,et al.  A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial , 1979, The British journal of surgery.

[50]  G. Zimmerman,et al.  Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils , 1991, The Journal of cell biology.

[51]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[52]  T. Standiford,et al.  MCP-1 expression by rat type II alveolar epithelial cells in primary culture. , 1993, Journal of immunology.

[53]  T. Standiford,et al.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.

[54]  G. Kaplan,et al.  The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin , 1987, The Journal of experimental medicine.

[55]  T. Standiford,et al.  Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. , 1990, American journal of respiratory cell and molecular biology.

[56]  R. Schaub,et al.  Early events in the formation of a venous thrombus following local trauma and stasis. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[57]  R. Strieter,et al.  Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. , 1990, The American journal of pathology.

[58]  D. E. Strandness,et al.  Valvular reflux after deep vein thrombosis: incidence and time of occurrence. , 1992, Journal of vascular surgery.

[59]  A. Anisowicz,et al.  Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Miyasaka,et al.  Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA‐1 subunit‐specific monoclonal antibodies , 1991, European journal of immunology.

[61]  M. Krangel,et al.  Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. , 1992, Critical reviews in immunology.

[62]  J. Millet,et al.  A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations. , 1987, Thrombosis research.

[63]  J. Han,et al.  Interleukin-1, endotoxin or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells. , 1989, Thrombosis research.

[64]  T. Fahey,et al.  Macrophage inflammatory protein 1 modulates macrophage function. , 1992, Journal of immunology.

[65]  A. Cerami,et al.  Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen. , 1989, Science.

[66]  A. Sica,et al.  Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. , 1990, Journal of immunology.

[67]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.